Log In
BCIQ
Print this Print this
 

TP-6076

  Manage Alerts
Collapse Summary General Information
Company Tetraphase Pharmaceuticals Inc.
DescriptionUndisclosed tetracycline-derived compound
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationGram-negative bacterial infection
Indication DetailsTreat multidrug-resistant Gram-negative bacterial infections
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today